Selected research
Industry Growth & Trends
Global Universal Tissue Fixative Industry Growth and Trends Forecast to 2032
Market perspective
The global Universal Tissue Fixative market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Universal Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Universal Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Universal Tissue Fixative is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Universal Tissue Fixative include Yeasen Biotechnology, Servicebio, Boster Biological Technology, Sangon Biotech, Thermo Fisher Scientific, Saiguo Biotechnology, Liaoshiyuan Biomedical Technology, Leagene and Heyuan Liji (Shanghai) Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Universal Tissue Fixative market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Universal Tissue Fixative market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Universal Tissue Fixative market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Universal Tissue Fixative.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Universal Tissue Fixative market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Universal Tissue Fixative Market by Company
Yeasen Biotechnology
Servicebio
Boster Biological Technology
Sangon Biotech
Thermo Fisher Scientific
Saiguo Biotechnology
Liaoshiyuan Biomedical Technology
Leagene
Heyuan Liji (Shanghai) Biotechnology
Beyotime
Bestbio
Absin
Wako
Leica Biosystems
Biotium
Biosharp
Abcam
Universal Tissue Fixative Segment by Type
Aldehyde mixtures
Formalin-based
Phenol-containing
Alcohol-based
Universal Tissue Fixative Segment by Application
Histology and Pathological Diagnosis
Immunohistochemistry
Molecular Biology Applications
Other
Universal Tissue Fixative Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Universal Tissue Fixative market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Universal Tissue Fixative and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Universal Tissue Fixative.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Universal Tissue Fixative manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Universal Tissue Fixative in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aldehyde mixtures
- Formalin-based
- Phenol-containing
- Alcohol-based
Applications
- Histology and Pathological Diagnosis
- Immunohistochemistry
- Molecular Biology Applications
- Other
Companies covered
- Yeasen Biotechnology
- Servicebio
- Boster Biological Technology
- Sangon Biotech
- Thermo Fisher Scientific
- Saiguo Biotechnology
- Liaoshiyuan Biomedical Technology
- Leagene
- Heyuan Liji (Shanghai) Biotechnology
- Beyotime
- Bestbio
- Absin
- Wako
- Leica Biosystems
- Biotium
- Biosharp
- Abcam
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Universal Tissue Fixative Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Universal Tissue Fixative Sales Estimates and Forecasts (2021-2032)
- 1.3 Universal Tissue Fixative Market by Type
- 1.3.1 Aldehyde mixtures
- 1.3.2 Formalin-based
- 1.3.3 Phenol-containing
- 1.3.4 Alcohol-based
- 1.4 Global Universal Tissue Fixative Market Size by Type
- 1.4.1 Global Universal Tissue Fixative Market Size Overview by Type (2021-2032)
- 1.4.2 Global Universal Tissue Fixative Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Universal Tissue Fixative Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Universal Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Universal Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Universal Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Universal Tissue Fixative Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Universal Tissue Fixative Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Universal Tissue Fixative Industry Trends
- 2.2 Universal Tissue Fixative Industry Drivers
- 2.3 Universal Tissue Fixative Industry Opportunities and Challenges
- 2.4 Universal Tissue Fixative Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Universal Tissue Fixative Revenue (2021-2026)
- 3.2 Global Top Players by Universal Tissue Fixative Sales (2021-2026)
- 3.3 Global Top Players by Universal Tissue Fixative Price (2021-2026)
- 3.4 Global Universal Tissue Fixative Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Universal Tissue Fixative Major Company Production Sites & Headquarters
- 3.6 Global Universal Tissue Fixative Company, Product Type & Application
- 3.7 Global Universal Tissue Fixative Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Universal Tissue Fixative Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Universal Tissue Fixative Players Market Share by Revenue in 2025
- 3.8.3 2025 Universal Tissue Fixative Tier 1, Tier 2, and Tier 3
4 Universal Tissue Fixative Regional Status and Outlook
- 4.1 Global Universal Tissue Fixative Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Universal Tissue Fixative Historic Market Size by Region
- 4.2.1 Global Universal Tissue Fixative Sales in Volume by Region (2021-2026)
- 4.2.2 Global Universal Tissue Fixative Sales in Value by Region (2021-2026)
- 4.2.3 Global Universal Tissue Fixative Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Universal Tissue Fixative Forecasted Market Size by Region
- 4.3.1 Global Universal Tissue Fixative Sales in Volume by Region (2027-2032)
- 4.3.2 Global Universal Tissue Fixative Sales in Value by Region (2027-2032)
- 4.3.3 Global Universal Tissue Fixative Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Universal Tissue Fixative by Application
- 5.1 Universal Tissue Fixative Market by Application
- 5.1.1 Histology and Pathological Diagnosis
- 5.1.2 Immunohistochemistry
- 5.1.3 Molecular Biology Applications
- 5.1.4 Other
- 5.2 Global Universal Tissue Fixative Market Size by Application
- 5.2.1 Global Universal Tissue Fixative Market Size Overview by Application (2021-2032)
- 5.2.2 Global Universal Tissue Fixative Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Universal Tissue Fixative Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Universal Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Universal Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Universal Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Universal Tissue Fixative Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Universal Tissue Fixative Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Yeasen Biotechnology
- 6.1.1 Yeasen Biotechnology Company Information
- 6.1.2 Yeasen Biotechnology Business Overview
- 6.1.3 Yeasen Biotechnology Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Yeasen Biotechnology Universal Tissue Fixative Product Portfolio
- 6.1.5 Yeasen Biotechnology Recent Developments
- 6.2 Servicebio
- 6.2.1 Servicebio Company Information
- 6.2.2 Servicebio Business Overview
- 6.2.3 Servicebio Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Servicebio Universal Tissue Fixative Product Portfolio
- 6.2.5 Servicebio Recent Developments
- 6.3 Boster Biological Technology
- 6.3.1 Boster Biological Technology Company Information
- 6.3.2 Boster Biological Technology Business Overview
- 6.3.3 Boster Biological Technology Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Boster Biological Technology Universal Tissue Fixative Product Portfolio
- 6.3.5 Boster Biological Technology Recent Developments
- 6.4 Sangon Biotech
- 6.4.1 Sangon Biotech Company Information
- 6.4.2 Sangon Biotech Business Overview
- 6.4.3 Sangon Biotech Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sangon Biotech Universal Tissue Fixative Product Portfolio
- 6.4.5 Sangon Biotech Recent Developments
- 6.5 Thermo Fisher Scientific
- 6.5.1 Thermo Fisher Scientific Company Information
- 6.5.2 Thermo Fisher Scientific Business Overview
- 6.5.3 Thermo Fisher Scientific Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Thermo Fisher Scientific Universal Tissue Fixative Product Portfolio
- 6.5.5 Thermo Fisher Scientific Recent Developments
- 6.6 Saiguo Biotechnology
- 6.6.1 Saiguo Biotechnology Company Information
- 6.6.2 Saiguo Biotechnology Business Overview
- 6.6.3 Saiguo Biotechnology Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Saiguo Biotechnology Universal Tissue Fixative Product Portfolio
- 6.6.5 Saiguo Biotechnology Recent Developments
- 6.7 Liaoshiyuan Biomedical Technology
- 6.7.1 Liaoshiyuan Biomedical Technology Company Information
- 6.7.2 Liaoshiyuan Biomedical Technology Business Overview
- 6.7.3 Liaoshiyuan Biomedical Technology Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Liaoshiyuan Biomedical Technology Universal Tissue Fixative Product Portfolio
- 6.7.5 Liaoshiyuan Biomedical Technology Recent Developments
- 6.8 Leagene
- 6.8.1 Leagene Company Information
- 6.8.2 Leagene Business Overview
- 6.8.3 Leagene Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Leagene Universal Tissue Fixative Product Portfolio
- 6.8.5 Leagene Recent Developments
- 6.9 Heyuan Liji (Shanghai) Biotechnology
- 6.9.1 Heyuan Liji (Shanghai) Biotechnology Company Information
- 6.9.2 Heyuan Liji (Shanghai) Biotechnology Business Overview
- 6.9.3 Heyuan Liji (Shanghai) Biotechnology Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Heyuan Liji (Shanghai) Biotechnology Universal Tissue Fixative Product Portfolio
- 6.9.5 Heyuan Liji (Shanghai) Biotechnology Recent Developments
- 6.10 Beyotime
- 6.10.1 Beyotime Company Information
- 6.10.2 Beyotime Business Overview
- 6.10.3 Beyotime Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Beyotime Universal Tissue Fixative Product Portfolio
- 6.10.5 Beyotime Recent Developments
- 6.11 Bestbio
- 6.11.1 Bestbio Company Information
- 6.11.2 Bestbio Business Overview
- 6.11.3 Bestbio Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Bestbio Universal Tissue Fixative Product Portfolio
- 6.11.5 Bestbio Recent Developments
- 6.12 Absin
- 6.12.1 Absin Company Information
- 6.12.2 Absin Business Overview
- 6.12.3 Absin Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Absin Universal Tissue Fixative Product Portfolio
- 6.12.5 Absin Recent Developments
- 6.13 Wako
- 6.13.1 Wako Company Information
- 6.13.2 Wako Business Overview
- 6.13.3 Wako Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Wako Universal Tissue Fixative Product Portfolio
- 6.13.5 Wako Recent Developments
- 6.14 Leica Biosystems
- 6.14.1 Leica Biosystems Company Information
- 6.14.2 Leica Biosystems Business Overview
- 6.14.3 Leica Biosystems Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Leica Biosystems Universal Tissue Fixative Product Portfolio
- 6.14.5 Leica Biosystems Recent Developments
- 6.15 Biotium
- 6.15.1 Biotium Company Information
- 6.15.2 Biotium Business Overview
- 6.15.3 Biotium Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Biotium Universal Tissue Fixative Product Portfolio
- 6.15.5 Biotium Recent Developments
- 6.16 Biosharp
- 6.16.1 Biosharp Company Information
- 6.16.2 Biosharp Business Overview
- 6.16.3 Biosharp Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Biosharp Universal Tissue Fixative Product Portfolio
- 6.16.5 Biosharp Recent Developments
- 6.17 Abcam
- 6.17.1 Abcam Company Information
- 6.17.2 Abcam Business Overview
- 6.17.3 Abcam Universal Tissue Fixative Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Abcam Universal Tissue Fixative Product Portfolio
- 6.17.5 Abcam Recent Developments
7 North America by Country
- 7.1 North America Universal Tissue Fixative Sales by Country
- 7.1.1 North America Universal Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Universal Tissue Fixative Sales by Country (2021-2026)
- 7.1.3 North America Universal Tissue Fixative Sales Forecast by Country (2027-2032)
- 7.2 North America Universal Tissue Fixative Market Size by Country
- 7.2.1 North America Universal Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Universal Tissue Fixative Market Size by Country (2021-2026)
- 7.2.3 North America Universal Tissue Fixative Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Universal Tissue Fixative Sales by Country
- 8.1.1 Europe Universal Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Universal Tissue Fixative Sales by Country (2021-2026)
- 8.1.3 Europe Universal Tissue Fixative Sales Forecast by Country (2027-2032)
- 8.2 Europe Universal Tissue Fixative Market Size by Country
- 8.2.1 Europe Universal Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Universal Tissue Fixative Market Size by Country (2021-2026)
- 8.2.3 Europe Universal Tissue Fixative Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Universal Tissue Fixative Sales by Country
- 9.1.1 Asia-Pacific Universal Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Universal Tissue Fixative Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Universal Tissue Fixative Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Universal Tissue Fixative Market Size by Country
- 9.2.1 Asia-Pacific Universal Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Universal Tissue Fixative Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Universal Tissue Fixative Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Universal Tissue Fixative Sales by Country
- 10.1.1 South America Universal Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Universal Tissue Fixative Sales by Country (2021-2026)
- 10.1.3 South America Universal Tissue Fixative Sales Forecast by Country (2027-2032)
- 10.2 South America Universal Tissue Fixative Market Size by Country
- 10.2.1 South America Universal Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Universal Tissue Fixative Market Size by Country (2021-2026)
- 10.2.3 South America Universal Tissue Fixative Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Universal Tissue Fixative Sales by Country
- 11.1.1 Middle East and Africa Universal Tissue Fixative Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Universal Tissue Fixative Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Universal Tissue Fixative Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Universal Tissue Fixative Market Size by Country
- 11.2.1 Middle East and Africa Universal Tissue Fixative Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Universal Tissue Fixative Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Universal Tissue Fixative Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Universal Tissue Fixative Value Chain Analysis
- 12.1.1 Universal Tissue Fixative Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Universal Tissue Fixative Production Mode & Process
- 12.2 Universal Tissue Fixative Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Universal Tissue Fixative Distributors
- 12.2.3 Universal Tissue Fixative Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst